SB
IMTX icon

Samsara BioCapital’s Immatics IMTX Stock Holding History

Samsara BioCapital’s Portfolio IMTX Stock Details IMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-198,000
Closed -$1.41M – 40
2024
Q4 		$1.41M Hold
198,000
– – 0.19% 31
2024
Q3 		$2.26M Hold
198,000
– – 0.43% 27
2024
Q2 		$2.3M Sell
198,000
-198,000
-50% -$2.23M 0.48% 28
2024
Q1 		$4.16M Hold
396,000
– – 0.64% 25
2023
Q4 		$4.17M Hold
396,000
– – 0.65% 23
2023
Q3 		$4.59M Hold
396,000
– – 1.4% 20
2023
Q2 		$4.57M Sell
396,000
-99,000
-20% -$924K 0.8% 22
2023
Q1 		$3.42M Hold
495,000
– – 0.71% 26
2022
Q4 		$4.31M Buy
+495,000
New +$5.12M 0.93% 24

Other funds holding IMTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Samsara BioCapital's IMTX Position: Q1 2025 in Review

Samsara BioCapital sold out of Immatics (IMTX) in Q1 2025, closing a stake of 198,000 shares — an estimated $1.41M sold.

Samsara BioCapital first reported a position in IMTX in Q4 2022 and held it in 9 quarters. The position peaked at $4.59M in Q3 2023. 76 funds tracked by Wall St. Rank hold IMTX as of Q1 2025.

  • Samsara BioCapital reported no remaining Immatics position as of Q1 2025 after selling out during the quarter.
  • Samsara BioCapital sold 198,000 Immatics shares in Q1 2025, an estimated $1.41M.
  • Samsara BioCapital first reported a position in Immatics in Q4 2022 and held it in 9 quarters.
  • Samsara BioCapital's Immatics position peaked at $4.59M in Q3 2023.
  • 76 funds tracked by Wall St. Rank held Immatics as of Q1 2025.

Based on Samsara BioCapital's 13F filing for Q1 2025, filed 15 May 2025.